Digestive Disease Week 2022

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

San Diego, CA, United States
May 21, 2022 - May 24, 2022
DDW is the world’s premier meeting for physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Visit the conference website for more details.

News

DDW 2022: Investigational Liver-Targeted Therapy Proves Promising Therapeutic for Celiac Disease

PracticeUpdate Editorial Team · June 05, 2022

DDW
DDW 2022: Large Families and Dog Ownership Associated With Reduced Risk of Crohn’s Disease Onset

PracticeUpdate Editorial Team · June 05, 2022

DDW
DDW 2022: Switching From Intravenous to Subcutaneous Infliximab for Inflammatory Bowel Disease is Safe, Even in Patients Receiving Intensified Regimens

PracticeUpdate Editorial Team · June 04, 2022

DDW
DDW 2022: Buprenorphine Outperforms Diclofenac as Pain Control for Acute Pancreatitis

PracticeUpdate Editorial Team · June 04, 2022

DDW
DDW 2022: Investigational Oral Microbiome Therapy CD101 Reduces Recurrences of Clostridioides difficile Infection

PracticeUpdate Editorial Team · June 03, 2022

DDW
DDW 2022: Guselkumab Shows Promise in Moderately to Severely Active Ulcerative Colitis

PracticeUpdate Editorial Team · June 03, 2022

DDW
DDW 2022: Long-Term Proton Pump Inhibitor Use Not a Risk Factor for Cognitive Decline

PracticeUpdate Editorial Team · June 02, 2022

DDW
DDW 2022: Cold Forceps as Good as Cold Snare for Removal of Small Polyps During Colonoscopy

PracticeUpdate Editorial Team · June 02, 2022

DDW
DDW 2022: Immunomodulator Withdrawal Does Not Increase Risk of Loss of Response to Anti-TNFα Therapy for Inflammatory Bowel Disease

PracticeUpdate Editorial Team · June 01, 2022

DDW
DDW 2022: Vedolizumab Offers Less Efficacy Without Any Safety Benefit Over TNFα Antagonists in Older Patients With Inflammatory Bowel Disease

PracticeUpdate Editorial Team · June 01, 2022

DDW

Digestive Disease Week 2022

News

DDW 2022: Investigational Liver-Targeted Therapy Proves Promising Therapeutic for Celiac Disease

DDW 2022: Large Families and Dog Ownership Associated With Reduced Risk of Crohn’s Disease Onset

DDW 2022: Switching From Intravenous to Subcutaneous Infliximab for Inflammatory Bowel Disease is Safe, Even in Patients Receiving Intensified Regimens

DDW 2022: Buprenorphine Outperforms Diclofenac as Pain Control for Acute Pancreatitis

DDW 2022: Investigational Oral Microbiome Therapy CD101 Reduces Recurrences of Clostridioides difficile Infection

DDW 2022: Guselkumab Shows Promise in Moderately to Severely Active Ulcerative Colitis

DDW 2022: Long-Term Proton Pump Inhibitor Use Not a Risk Factor for Cognitive Decline

DDW 2022: Cold Forceps as Good as Cold Snare for Removal of Small Polyps During Colonoscopy

DDW 2022: Immunomodulator Withdrawal Does Not Increase Risk of Loss of Response to Anti-TNFα Therapy for Inflammatory Bowel Disease

DDW 2022: Vedolizumab Offers Less Efficacy Without Any Safety Benefit Over TNFα Antagonists in Older Patients With Inflammatory Bowel Disease

No Content

Recently Updated